According to Arcadia Biosciences's latest financial reports the company's total assets are ยฃ9.72 Million. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | ยฃ15.46 M | -35.3% |
2022-12-31 | ยฃ23.9 M | -26.52% |
2021-12-31 | ยฃ32.53 M | -6.34% |
2020-12-31 | ยฃ34.73 M | 39.84% |
2019-12-31 | ยฃ24.84 M | 31.25% |
2018-12-31 | ยฃ18.92 M | 54.37% |
2017-12-31 | ยฃ12.26 M | -73.26% |
2016-12-31 | ยฃ45.84 M | -8.48% |
2015-12-31 | ยฃ50.09 M | 213.39% |
2014-12-31 | ยฃ15.98 M | 176.35% |
2013-12-31 | ยฃ5.78 M | -30.01% |
2012-12-31 | ยฃ8.26 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
![]() Marrone Bio Innovations
MBII | N/A | N/A | ๐บ๐ธ USA |
![]() American Vanguard AVD | ยฃ0.47 B | 4,762.11% | ๐บ๐ธ USA |
![]() ScottsMiracle-Gro SMG | ยฃ2.64 B | 27,126.33% | ๐บ๐ธ USA |
![]() Codexis
CDXS | ยฃ96.51 M | 892.20% | ๐บ๐ธ USA |